MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The role of cortical and subcortical structures in maintaining efficient network topology in Parkinson’s disease

    R. Berlot, B. Koritnik, Z. Pirtošek (Ljubljana, Slovenia)

    Objective: To assess the relative importance of cortical and subcortical nodes and their connections in maintaining efficient structural connectome topology in Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Pooled safety analysis of incobotulinumtoxinA in the treatment of neurological disorders in adults

    C. Comella, M. Hast, A. Hanschmann (Chicago, USA)

    Objective: To examine the pooled incidence of treatment-emergent adverse events (TEAEs) and immunogenicity by indication in sponsored incobotulinumtoxinA (INCO) clinical trials in adults. Background: The…
  • 2022 International Congress

    Boostering motor imagery processing to improve gait in patients with Parkinson disease and freezing of gait: a preliminary study

    S. Mezzarobba, E. Ravizzotti, P. Bernardis, M. Putzolu, C. Cosentino, A. Botta, G. Bonassi, R. Marchese, L. Avanzino, E. Pelosin (Genoa, Italy)

    Objective: The aim of this study is to evaluate the priming effect of visual, auditory and cognitive tasks in enhancing Motor Imagery (MI) ability in…
  • 2022 International Congress

    Does Patients with Parkinson diseases have distinctive PD personality? An insight on the phenomenology of Parkinson’s Disease

    GB. Eow, K. Tan, HJ. Tan, HY. Ch'Ng, TS. Thannimalai, TH. Lee, TT. Lim, R. Bhidayasari, WY. Ooi, MY. Wong (George Town, Malaysia)

    Objective: To raise awareness in Parkinson Disease personality to encourage them to make changes to their mentality in order to be more flexible. This is…
  • 2022 International Congress

    Nutritional Status in Advanced Parkinson’s Disease: Preliminary Results.

    N. Ayo (Barakaldo, Spain)

    Objective: To analyze the relationship between nutritional intake and weight aspects in 3 groups of patients with Parkinson's disease (PD) who are receiving different pharmacological…
  • 2022 International Congress

    Language Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder and de-novo Parkinson’s disease

    M. šubert, M. šimek, M. Novotný, T. Tykalová, O. Bezdíček, E. Růžička, K. šonka, P. Dušek, J. Rusz (Prague 6, Czech Republic)

    Objective: This study aimed to examine whether the language impairment is presented in isolated rapid eye movement sleep behavior disorder (iRBD) and early-stage Parkinson’s disease…
  • 2022 International Congress

    A randomized clinical trial (RCT) to evaluate the effects of safinamide on apathetic non-demented Parkinson’s disease patients

    J. Kulisevsky, S. Martinez-Horta, A. Campolongo, B. Pascual-Sedano, J. Marin-Lahoz, H. Bejr-Kasem, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, I. Aracil-Bolaños, J. Rodriguez-Antiguedad (Barcelona, Spain)

    Objective: To evaluate the safety and effects of add-on safinamide on apathy in patients with Parkinson’s disease (PD). Background: Apathy is highly prevalent and disabling…
  • 2022 International Congress

    Very long time persistent hyperCKemia as the first manifestation of McLeod syndrome

    E. Muñoz, V. Torres, C. Painous, P. Santacruz, A. Sánchez, C. Sanz, JM. Grau-Junyent (Barcelona, Spain)

    Objective: To present a case of McLeod syndrome (MLS) with isolated muscle involvement for many years, which developed late-onset chorea leading to disease diagnosis. Background:…
  • 2022 International Congress

    Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism

    A. Murakami, S. Koga, S. Fujioka, K. Bieniek, H. Sekiya, M. Nakamura, Y. Tsuboi, M. Murray, Z. Wszolek, D. Dickson (Jacksonville, USA)

    Objective: To clarify clinicopathologic features of pathologically-confirmed primary lateral sclerosis (PLS). Background: PLS is a neurodegenerative disorder characterized by slowly progressive upper motor neuron signs…
  • 2022 International Congress

    Deep Brain Stimulation in Generalized Dystonia Caused by PRKRA Mutation

    A. Falcone, C. Listik, S. Barbosa Casagrande, M. Torres, D. Boari Coelho, L. Augusto Teixeira, J. Papaterra Limongi, M. Jacobsen Teixeira, E. Reis Barbosa, R. Cury (Caçapava, Brazil)

    Objective: Dystonia is a hyperkinetic movement disorder with a complex pathophysiology. The medical treatment includes pharmacological treatment, including botulinum toxin (BoNT), which is considered the…
  • « Previous Page
  • 1
  • …
  • 786
  • 787
  • 788
  • 789
  • 790
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley